Hematopoietic Protein Tyrosine Phosphatase Mediates β₂-Adrenergic Receptor-Induced Regulation of p38 Mitogen-Activated Protein Kinase in B Lymphocytes

REFERENCES

• Abramson, M. J., J. Walters, and E. H. Walters. 2003. Adverse effects of beta-agonists: are they clinically relevant? Am. J. Respir. Med. 2:287–297.
   PubMedGoogle Scholar
• Ashwell, J. D. 2006. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat. Rev. Immunol. 6:532–540.
   PubMed Web of Science ®Google Scholar
• Azzi, M., P. G. Charest, S. Angers, G. Rousseau, T. Kohout, M. Bouvier, and G. Pineyro. 2003. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 100:11406–11411.
   PubMed Web of Science ®Google Scholar
• Bos, J. L. 2003. Epac: a new cAMP target and new avenues in cAMP research. Nat. Rev. Mol. Cell Biol. 4:733–738.
   PubMed Web of Science ®Google Scholar
• Burrows, B., F. D. Martinez, M. Halonen, R. A. Barbee, and M. G. Cline. 1989. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N. Engl. J. Med. 320:271–280.
   PubMed Web of Science ®Google Scholar
• Canfield, S., Y. Lee, A. Schroder, and P. Rothman. 2005. Cutting edge: IL-4 induces suppressor of cytokine signaling-3 expression in B cells by a mechanism dependent on activation of p38 MAPK. J. Immunol. 174:2494–2498.
   PubMedGoogle Scholar
• Chrzanowska-Wodnicka, M., A. E. Kraus, D. Gale, G. C. I. White, and J. Vansluys. 2008. Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood 111:2647–2656.
   PubMed Web of Science ®Google Scholar
• Communal, C., W. S. Colucci, and K. Singh. 2000. p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta-adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation. J. Biol. Chem. 275:19395–19400.
   PubMed Web of Science ®Google Scholar
• Coyle, A. J., K. Wagner, C. Bertrand, S. Tsuyuki, J. Bews, and C. Heusser. 1996. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med. 183:1303–1310.
   PubMed Web of Science ®Google Scholar
• Craxton, A., G. Shu, J. D. Graves, J. Saklatvala, E. G. Krebs, and E. A. Clark. 1998. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J. Immunol. 161:3225–3236.
   PubMed Web of Science ®Google Scholar
• Gronda, M., S. Arab, B. Iafrate, H. Suzuki, and B. W. Zanke. 2001. Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation. Mol. Cell. Biol. 21:6851–6858.
   PubMedGoogle Scholar
• Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808–811.
   PubMed Web of Science ®Google Scholar
• Haughton, G., L. W. Arnold, G. A. Bishop, and T. J. Mercolino. 1986. The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol. Rev. 93:35–51.
   PubMedGoogle Scholar
• Kasprowicz, D. J., A. P. Kohm, M. T. Berton, A. J. Chruscinski, A. H. Sharpe, and V. M. Sanders. 2000. Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell. J. Immunol. 165:680–690.
   PubMed Web of Science ®Google Scholar
• Kohm, A. P., A. Mozaffarian, and V. M. Sanders. 2002. B cell receptor- and beta-2-adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells. J. Immunol. 168:6314–6322.
   PubMed Web of Science ®Google Scholar
• Kohm, A. P., and V. M. Sanders. 1999. Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J. Immunol. 162:5299–5308.
   PubMed Web of Science ®Google Scholar
• Kohm, A. P., Y. Tang, V. M. Sanders, and S. B. Jones. 2000. Activation of antigen-specific CD4+ Th2 cells and B cells in vivo increases norepinephrine release in the spleen and bone marrow. J. Immunol. 165:725–733.
   PubMed Web of Science ®Google Scholar
• Krasel, C., M. Bunemann, K. Lorenz, and M. J. Lohse. 2005. Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J. Biol. Chem. 280:9528–9535.
   PubMedGoogle Scholar
• Lefkowitz, R. J., and S. K. Shenoy. 2005. Transduction of receptor signals by beta-arrestins. Science 308:512–517.
   PubMed Web of Science ®Google Scholar
• Lopez-Ilasaca, M. 1998. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem. Pharmacol. 56:269–277.
   PubMed Web of Science ®Google Scholar
• Lopez-Ilasaca, M., P. Crespo, P. G. Pellici, J. S. Gutkind, and R. Wetzker. 1997. Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 275:394–397.
   PubMed Web of Science ®Google Scholar
• Moule, S. K., and R. M. Denton. 1998. The activation of p38 MAPK by the beta-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett. 439:287–290.
   PubMed Web of Science ®Google Scholar
• Muñoz, J. J., C. Tarrega, C. Blanco-Aparicio, and R. Pulido. 2003. Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents. Biochem. J. 372:193–201.
   PubMedGoogle Scholar
• Mustelin, T., A. Alonso, N. Bottini, H. Huynh, S. Rahmouni, K. Nika, C. Louis-dit-Sully, L. Tautz, S. H. Togo, S. Bruckner, A. V. Mena-Duran, and A. M. al-Khouri. 2004. Protein tyrosine phosphatases in T cell physiology. Mol. Immunol. 41:687–700.
   PubMedGoogle Scholar
• Mustelin, T., K. M. Coggeshall, N. Isakov, and A. Altman. 1990. T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation. Science 247:1584–1587.
   PubMed Web of Science ®Google Scholar
• Mustelin, T., L. Tautz, and R. Page. 2005. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site. J. Mol. Biol. 354:150–163.
   PubMedGoogle Scholar
• Mustelin, T., T. Vang, and N. Bottini. 2005. Protein tyrosine phosphatases and the immune response. Nat. Rev. Immunol. 5:43–57.
   PubMed Web of Science ®Google Scholar
• Nance, D. M., and V. M. Sanders. 2007. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav. Immun. 21:736–745.
   PubMed Web of Science ®Google Scholar
• Nika, K., H. Hyunh, S. Williams, S. Paul, N. Bottini, K. Tasken, P. J. Lombroso, and T. Mustelin. 2004. Haematopoietic protein tyrosine phosphatase (HePTP) phosphorylation by cAMP-dependent protein kinase in T-cells: dynamics and subcellular location. Biochem. J. 378:335–342.
   PubMedGoogle Scholar
• Obata, T., G. E. Brown, and M. B. Yaffe. 2000. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit. Care Med. 28:N67–N77.
   PubMed Web of Science ®Google Scholar
• Oetken, C., M. von Willedbrand, M. Autero, T. Ruutu, L. C. Andersson, and T. Mustelin. 1992. Phenylarsine oxide augments tyrosine phosphorylation in hematopoietic cells. Eur. J. Haematol. 49:208–214.
   PubMedGoogle Scholar
• Oettgen, H. C., and R. S. Geha. 1999. IgE in asthma and atopy: cellular and molecular connections. J. Clin. Investig. 104:829–835.
   PubMed Web of Science ®Google Scholar
• O'Shea, J. J., D. W. McVicar, T. L. Bailey, C. Burns, and M. J. Smyth. 1992. Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc. Natl. Acad. Sci. USA 89:10306–10310.
   PubMedGoogle Scholar
• Peter, P. S., J. E. Brady, L. Yan, W. Chen, S. Engelhardt, Y. Wang, J. Sadoshima, S. F. Vatner, and D. E. Vatner. 2007. Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor. J. Clin. Investig. 117:1335–1343.
   PubMedGoogle Scholar
• Pierce, K. L., R. T. Premont, and R. J. Lefkowitz. 2002. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3:639–650.
   PubMed Web of Science ®Google Scholar
• Podojil, J. R., N. W. Kin, and V. M. Sanders. 2004. CD86 and beta2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B expression and binding to the 3′-IgH enhancer in B cells. J. Biol. Chem. 279:23394–23404.
   PubMedGoogle Scholar
• Podojil, J. R., and V. M. Sanders. 2003. Selective regulation of mature IgG1 transcription by CD86 and beta2-adrenergic receptor stimulation. J. Immunol. 170:5143–5151.
   PubMedGoogle Scholar
• Pongratz, G., J. W. McAlees, D. H. Conrad, R. S. Erbe, K. M. Haas, and V. M. Sanders. 2006. The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner. J. Immunol. 177:2926–2938.
   PubMedGoogle Scholar
• Raingeaud, J., S. Gupta, J. S. Roger, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420–7426.
   PubMed Web of Science ®Google Scholar
• Sanders, V. M., and F. E. Powell-Oliver. 1992. Beta-2-adrenoceptor stimulation increases the number of antigen-specific precursor B lymphocytes that differentiate into IgM-secreting cells without affecting burst size. J. Immunol. 148:1822–1828.
   PubMed Web of Science ®Google Scholar
• Saxena, M., S. Williams, K. Tasken, and T. Mustelin. 1999. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat. Cell Biol. 1:305–311.
   PubMed Web of Science ®Google Scholar
• Secrist, J. P., L. A. Burns, L. Karnitz, G. A. Koretzky, and R. T. Abraham. 1993. Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol. Chem. 268:5886–5893.
   PubMed Web of Science ®Google Scholar
• Seino, S., and T. Shibasaki. 2005. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol. Rev. 85:1303–1342.
   PubMed Web of Science ®Google Scholar
• Shen, C. H., and J. Stavnezer. 2001. Activation of the mouse Ig germline epsilon promoter by IL-4 is dependent on AP-1 transcription factors. J. Immunol. 66:411–423.
   Google Scholar
• Shenoy, S. K., M. T. Drake, C. D. Nelson, D. A. Houtz, K. Xiao, S. Madabushi, E. Reiter, R. T. Premont, O. Lichtarge, and R. J. Lefkowitz. 2006. Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J. Biol. Chem. 281:1261–1273.
   PubMed Web of Science ®Google Scholar
• Shenoy, S. K., and R. J. Lefkowitz. 2003. Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem. J. 375:503–515.
   PubMed Web of Science ®Google Scholar
• Ster, J., F. De Bock, N. C. Guérineau, A. Janossy, S. Barrère-Lemaire, J. L. Bos, J. Bockaert, and L. Fagni. 2007. Exchange protein activated by cAMP (Epac) mediates cAMP activation of p38 MAPK and modulation of Ca2+-dependent K+ channels in cerebellar neurons. Proc. Natl. Acad. Sci. USA 104:2519–2524.
   PubMedGoogle Scholar
• Sutherland, C. L., A. W. Heath, S. L. Pelech, P. R. Young, and M. R. Gold. 1996. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J. Immunol. 157:3381–3390.
   PubMed Web of Science ®Google Scholar
• Swart, J. M., D. M. Bergerson, and T. C. Chiles. 2000. Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas. J. Immunol. 164:2311–2319.
   PubMedGoogle Scholar
• Tautz, L., and T. Mustelin. 2007. Strategies for developing protein tyrosine phosphatase inhibitors. Methods 42:250–260.
   PubMedGoogle Scholar
• Tran, T. M., J. Friedman, E. Qunaibi, F. Baameur, R. H. Moore, and R. B. Clark. 2004. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies. Mol. Pharmacol. 65:196–206.
   PubMedGoogle Scholar
• Vang, T., A. V. Miletic, Y. Arimura, L. Tautz, R. C. Rickert, and T. Mustelin. 2008. Protein tyrosine phosphatases in autoimmunity. Annu. Rev. Immunol. 26:29–55.
   PubMed Web of Science ®Google Scholar
• Vossler, M. R., H. Yao, R. D. York, M. G. Pan, C. S. Rim, and P. J. Stork. 1997. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89:73–82.
   PubMed Web of Science ®Google Scholar
• Wu, Z., P. J. Woodring, K. S. Bhakta, K. Tamura, F. Wen, J. R. Feramisco, M. Karin, J. Y. Wang, and P. L. Puri. 2000. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell. Biol. 2000:3951–3964.
   Google Scholar
• Zamah, A. M., M. Delahunty, L. M. Luttrell, and R. J. Lefkowitz. 2002. Protein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system. J. Biol. Chem. 277:31249–31256.
   PubMed Web of Science ®Google Scholar
• Zanke, B., H. Suzuki, K. Kishihara, L. Mizzen, M. Minden, A. Pawson, and T. W. Mak. 1992. Cloning and expression of an inducible lymphoid-specific, protein tyrosine phosphatase (HePTPase). Eur. J. Immunol. 22:235–239.
   PubMed Web of Science ®Google Scholar
• Zhang, C. Y., Y. L. Wu, and L. M. Boxer. 2002. Impaired proliferation and survival of activated B cells in transgenic mice that express a dominant-negative cAMP-response element-binding protein transcription factor in B cells. J. Biol. Chem. 277:48359–48365.
   PubMedGoogle Scholar
• Zheng, M., S. J. Zhang, W. Z. Zhu, B. Zinman, B. K. Kobilka, and R. P. Xiao. 2000. Beta 2-adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by Gi or Gbeta gamma in adult mouse cardiomyocytes. J. Biol. Chem. 275:40635–40640.
   PubMedGoogle Scholar